Inverness Medical Extends Distribution Agreement with Thermo Fisher Scientific

 

July 25, 2008

July 25, 2008 - Inverness Medical Innovations Inc. and Thermo Fisher Scientific have extended their cardiology products distribution relationship by two years through December 2010, which covers all cardiology and drugs of abuse rapid test products manufactured by Inverness’ subsidiary Biosite.

These tests are sold under the Triage brand and include tests for BNP, troponin, CK-MB, Myoglobin, d-dimer and a broad range of meter and visually read drugs of abuse tests.

Products sold for use on third party instruments, such as the BNP test sold by Inverness for use on Beckman immunoassay systems, are not included.

The modified financial terms of the new agreement were not disclosed.

For more information: www.invernessmedical.com.